These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35194061)

  • 1. The sterility, stability and efficacy of repackaged ziv-aflibercept for intravitreal administration.
    Juhong J; Pongsachareonnont PF; Somkijrungroj T; Mavichak A; Varadisai A; Chariyavilaskul P; Chatsuwan T; Suttichet TB; Kulvichit K
    Sci Rep; 2022 Feb; 12(1):2971. PubMed ID: 35194061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of aflibercept and ziv-aflibercept binding affinity to vascular endothelial growth factor, stability and sterility after compounding.
    de Lima Farah J; Sano R; Maugéri IML; Teixeira D; Ishimura ME; Martins G; Mimica LMJ; da Silva CB; Meyer CH; de Oliveira Dias JR; de Andrade GC; Farah ME
    Int J Retina Vitreous; 2018; 4():39. PubMed ID: 30386633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained Anti-Vascular Endothelial Growth Factor Activity of Aflibercept (Eylea) After Storage in Polycarbonate Syringes Used for Intravitreal Injection: A Pathway to Safety and Efficiency.
    Han DP; Skumatz C; Besharse JC; Kassem IS
    J Ocul Pharmacol Ther; 2019 Jun; 35(5):278-282. PubMed ID: 30916605
    [No Abstract]   [Full Text] [Related]  

  • 4. Ziv-aflibercept in macular disease.
    Mansour AM; Al-Ghadban SI; Yunis MH; El-Sabban ME
    Br J Ophthalmol; 2015 Aug; 99(8):1055-9. PubMed ID: 25677668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability study over time of clinical solutions of ziv-aflibercept prepared in infusion bags using a proper combination of physicochemical and functional strategies.
    Hermosilla J; Pérez-Robles R; Salmerón-García A; Casares S; Cabeza J; Navas N
    J Pharm Biomed Anal; 2021 Sep; 203():114209. PubMed ID: 34153938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Bioavailability of Complete and Half-Dose Intravitreal Ziv-Aflibercept in an Experimental Model: Contralateral Eye Study.
    Lashay A; Delrish E; Ashrafi E; Movassat M; Asadi-Amoli F; Dinarvand R; Abrishami M
    Ophthalmic Surg Lasers Imaging Retina; 2019 Dec; 50(12):785-790. PubMed ID: 31877224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term stability of bevacizumab repackaged in 1mL polypropylene syringes for intravitreal administration.
    Paul M; Vieillard V; Roumi E; Cauvin A; Despiau MC; Laurent M; Astier A
    Ann Pharm Fr; 2012 May; 70(3):139-54. PubMed ID: 22655582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability and sterility of meglumine gadoterate injection repackaged in plastic syringes.
    Micard S; Rieutord A; Prognon P; Hassan M; Brion F
    Int J Pharm; 2001 Jan; 212(1):93-9. PubMed ID: 11165824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion proteins for treatment of retinal diseases: aflibercept, ziv-aflibercept, and conbercept.
    de Oliveira Dias JR; de Andrade GC; Novais EA; Farah ME; Rodrigues EB
    Int J Retina Vitreous; 2016; 2():3. PubMed ID: 27847621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LONG-TERM PHYSICAL STABILITY, STERILITY, AND ANTI-VEGF BIOACTIVITY OF REPACKAGED BEVACIZUMAB IN 2-ML GLASS VIALS.
    Peterson JS; Rockwell K; Scott IU; Ip MS; VanVeldhuisen PC; Blodi BA;
    Retina; 2019 Sep; 39(9):1802-1809. PubMed ID: 29746405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification, microbial contamination, physico-chemical stability of repackaged bevacizumab stored under different conditions.
    Signorello L; Pucciarelli S; Bonacucina G; Polzonetti V; Cespi M; Perinelli DR; Palmieri GF; Pettinari R; Pettinari C; Fiorentini G; Vincenzetti S
    Curr Pharm Biotechnol; 2014; 15(2):113-9. PubMed ID: 24953231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal Toxicity of Intravitreal Injection of Ziv-Aflibercept in Albino Rabbits.
    Ramon D; Shahar J; Massarweh A; Man I; Perlman I; Loewenstein A
    Transl Vis Sci Technol; 2018 Nov; 7(6):23. PubMed ID: 30564512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability assessment of repackaged bevacizumab for intravitreal administration.
    Pereboom M; Becker ML; Amenchar M; Verweij SL; van der Hoeven RT; Mulder IJ
    Int J Pharm Compd; 2015; 19(1):70-2. PubMed ID: 25902630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of sterility in 1-mL polypropylene syringes.
    Gonzalez S; Miller D; Murphy SP
    Am J Health Syst Pharm; 2007 Sep; 64(18):1962-4. PubMed ID: 17823109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FLATTENING OF A TREATMENT-RESISTANT RETINAL PIGMENT EPITHELIAL DETACHMENT AFTER A SINGLE INTRAVITREAL INJECTION OF ZIV-AFLIBERCEPT.
    Yogi R; Stewart M; Chhablani J
    Retin Cases Brief Rep; 2017 Spring; 11(2):111-113. PubMed ID: 27078613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized, controlled phase III trial.
    Ramlau R; Gorbunova V; Ciuleanu TE; Novello S; Ozguroglu M; Goksel T; Baldotto C; Bennouna J; Shepherd FA; Le-Guennec S; Rey A; Miller V; Thatcher N; Scagliotti G
    J Clin Oncol; 2012 Oct; 30(29):3640-7. PubMed ID: 22965962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-Year Results of a Trial Comparing 2 Doses of Intravitreal Ziv-aflibercept versus Bevacizumab for Treatment of Diabetic Macular Edema.
    Jabbarpoor Bonyadi MH; Baghi A; Ramezani A; Yaseri M; Soheilian M
    Ophthalmol Retina; 2018 May; 2(5):428-440. PubMed ID: 31047323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the sterility, stability, and efficacy of bevacizumab stored in multiple-dose vials for 6 months.
    Chen YH; Wu PC; Shiea J; Lo LH; Wu YC; Kuo HK
    J Ocul Pharmacol Ther; 2009 Feb; 25(1):65-9. PubMed ID: 19232008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INTRAVITREAL INJECTIONS OF ZIV-AFLIBERCEPT FOR DIABETIC MACULAR EDEMA: A Pilot Study.
    Andrade GC; Dias JR; Maia A; Farah ME; Meyer CH; Rodrigues EB
    Retina; 2016 Sep; 36(9):1640-5. PubMed ID: 26991646
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.